发明名称 METHODS FOR ENHANCING IMMUNOSUPPRESSIVE THERAPY BY MULTIPLE ADMINISTRATION OF ALPHA BETA TCR-BINDING POLYPEPTIDE
摘要 The present disclosure is related to improved methods for use of a humanized binding polypeptide specific for the alpha beta T cell receptor (αβ-TCR). In particular, this disclosure relates to improved methods of use of a humanized anti-αβ-TCR antibody, which is derived from the murine monoclonal antibody BMA031, in immunosuppressive therapy. Novel methods using humanized monoclonal antibodies and/or humanized monoclonal antibody fragments (e.g., anti-αβTCR antibodies and/or fragments thereof) are also provided. Novel methods using repetitive administration of humanized monoclonal antibodies and/or humanized monoclonal antibody fragments (e.g., anti-αβTCR antibodies and/or fragments thereof) to reduce αβ T cells in the subject relative to γδ cells in the subject are provided.
申请公布号 US2016244523(A1) 申请公布日期 2016.08.25
申请号 US201415029770 申请日期 2014.10.30
申请人 GENZYME CORPORATION ;CHILDREN'S UNIVERSITY HOSPITAL TÜBINGEN 发明人 Blank Gregor;Handgretinger Rupert;Schilbach Karin;Lacorcia Gina;Snell Daniel;Menrad Andreas
分类号 C07K16/28 主分类号 C07K16/28
代理机构 代理人
主权项 1. A method of preferentially reducing αβ T cells relative to γδ T cells in a subject, comprising administering to the subject a humanized anti-αβTCR binding polypeptide in two or more doses.
地址 Cambridge MA US